MarliesOstermann United KingdomKing's College London

Professor Ostermann has a strong clinical and academic interest in acute kidney injury, critical care nephrology and extracorporeal blood purification.

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/05e6fc94e4829e69391e63b7da6c33ff.jpg

First name

Marlies

Last name

Ostermann

Institution

Country

United Kingdom

Saturday, February 8, 2025

Time	Session

9:45 a.m. 11:15 a.m.	Toward Complex Understanding of Kidney Function in AKI: Role of Biomarkers, Sex Differences and the Tropics; ISN-KSN Joint Session IK03 GirishNarayen Chair girishnarayan49@gmail.comIndiaChief of Nephrology division, udaiomni hospital, Hyderabad,India Hyeong CheonPark Chair amp97nody@gmail.comKorea (Republic of)Hyeong Cheon Park, Gangnam Severance Hospital, Yonsei University Prem PVarma Chair varmapp123@rediffmail.comIndiaPrincipal Director What Do We Know About the Association Between AKI and Long-Term Adverse Outcomes? IK03-01 Chi-yuanHsu Speaker Chi-yuan.Hsu@ucsf.eduUnited StatesUniversity of California, San Francisco Are Biomarkers in AKI Ready for Prime Time? IK03-02 ChiragParikh Speaker chirag.parikh@jhmi.eduUnited StatesJohns Hopkins University Community-acquired AKI in the Tropics - Is it a Different Disease? IK03-03 VivekKumar Speaker enigma165@yahoo.co.inIndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Sex as a Biological Variable in the Epidemiology of AKI IK03-04 MarliesOstermann Speaker Marlies.Ostermann@gstt.nhs.ukUnited KingdomKing's College London Q&A IK03-05 Amaltas Hall B101-A

Time

Session

9:45 a.m.

11:15 a.m.

Toward Complex Understanding of Kidney Function in AKI: Role of Biomarkers, Sex Differences and the Tropics; ISN-KSN Joint Session

IK03

GirishNarayen Chair girishnarayan49@gmail.comIndiaChief of Nephrology division, udaiomni hospital, Hyderabad,India

Hyeong CheonPark Chair amp97nody@gmail.comKorea (Republic of)Hyeong Cheon Park, Gangnam Severance Hospital, Yonsei University

Prem PVarma Chair varmapp123@rediffmail.comIndiaPrincipal Director

What Do We Know About the Association Between AKI and Long-Term Adverse Outcomes?

IK03-01

Chi-yuanHsu Speaker Chi-yuan.Hsu@ucsf.eduUnited StatesUniversity of California, San Francisco
Are Biomarkers in AKI Ready for Prime Time?

IK03-02

ChiragParikh Speaker chirag.parikh@jhmi.eduUnited StatesJohns Hopkins University
Community-acquired AKI in the Tropics - Is it a Different Disease?

IK03-03

VivekKumar Speaker enigma165@yahoo.co.inIndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India
Sex as a Biological Variable in the Epidemiology of AKI

IK03-04

MarliesOstermann Speaker Marlies.Ostermann@gstt.nhs.ukUnited KingdomKing's College London
Q&A

IK03-05

Amaltas Hall B101-A